These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29617346)

  • 1. Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.
    Akhtar A; Wang SX; Ghali L; Bell C; Wen X
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro.
    Akhtar A; Ghali L; Wang SX; Bell C; Li D; Wen X
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
    Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
    J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
    Wang H; Gao P; Zheng J
    Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide.
    Chen H; Ahn R; Van den Bossche J; Thompson DH; O'Halloran TV
    Mol Cancer Ther; 2009 Jul; 8(7):1955-63. PubMed ID: 19567824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
    Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
    Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
    Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
    Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel and efficient method for loading aptamer-conjugated liposomes with arsenic trioxide for targeting cancer cells.
    Mirveis Z; Kouchak M; Mahdavinia M; Rahbar N
    J Liposome Res; 2022 Sep; 32(3):276-283. PubMed ID: 34918592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release.
    Chen H; MacDonald RC; Li S; Krett NL; Rosen ST; O'Halloran TV
    J Am Chem Soc; 2006 Oct; 128(41):13348-9. PubMed ID: 17031934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide.
    He G; Wang Q; Zhou Y; Wu X; Wang L; Duru N; Kong X; Zhang P; Wan B; Sui L; Guo Q; Li JJ; Yu L
    Int J Gynecol Cancer; 2011 Aug; 21(6):1097-104. PubMed ID: 21792014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.
    Ahn RW; Chen F; Chen H; Stern ST; Clogston JD; Patri AK; Raja MR; Swindell EP; Parimi V; Cryns VL; O'Halloran TV
    Clin Cancer Res; 2010 Jul; 16(14):3607-17. PubMed ID: 20519360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential of Delivering Arsenic Trioxide into HPV-Infected Cervical Cancer Cells Using Liposomal Nanotechnology.
    Wang X; Li D; Ghali L; Xia R; Munoz LP; Garelick H; Bell C; Wen X
    Nanoscale Res Lett; 2016 Dec; 11(1):94. PubMed ID: 26887578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AS1411aptamer conjugated liposomes for targeted delivery of arsenic trioxide in mouse xenograft model of melanoma cancer.
    Shariat Razavi F; Kouchak M; Sistani Karampour N; Mahdavinia M; Nazari Khorasgani Z; Rezaie A; Rahbar N
    J Liposome Res; 2024 Jun; 34(2):288-302. PubMed ID: 37843918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide liposomes: encapsulation efficiency and in vitro stability.
    Kallinteri P; Fatouros D; Klepetsanis P; Antimisiaris SG
    J Liposome Res; 2004; 14(1-2):27-38. PubMed ID: 15461930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy.
    Saengkrit N; Saesoo S; Srinuanchai W; Phunpee S; Ruktanonchai UR
    Colloids Surf B Biointerfaces; 2014 Feb; 114():349-56. PubMed ID: 24246195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity.
    Wu X; Hu Z; Nizzero S; Zhang G; Ramirez MR; Shi C; Zhou J; Ferrari M; Shen H
    J Control Release; 2017 Dec; 268():92-101. PubMed ID: 29042320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.
    Huang A; Yue D; Liao D; Cheng L; Ma J; Wei Y; Tong A; Cheng P
    Oncol Rep; 2016 Dec; 36(6):3283-3290. PubMed ID: 27748945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
    Kanwar JR; Gibbons J; Verma AK; Kanwar RK
    Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.
    Khosravani F; Amiri F; Mahmoudi R; Morshedi D; Kobarfard F; Alipour M; Hosseini E; Bardania H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2347-2357. PubMed ID: 37831114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.
    Zhang S; Ma C; Pang H; Zeng F; Cheng L; Fang B; Ma J; Shi Y; Hong H; Chen J; Wang Z; Xia J
    Biochem Biophys Res Commun; 2016 Jan; 469(1):55-61. PubMed ID: 26592661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.